Samer Nassif
Papers
1
Total Citations
10
H-Index
1
About
Dr. Samer Nassif is a leading figure in nuclear oncology, with a focused expertise in the application of advanced molecular imaging for prostate cancer management. His most cited work critically evaluates the diagnostic performance of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography (Ga-68 PSMA PET/CT), a revolutionary imaging modality that offers superior sensitivity and specificity in detecting prostate cancer lesions by targeting PSMA expression. This seminal study, accumulating 10 citations, has helped validate the clinical utility of this technique for staging intermediate and high-risk prostate cancer patients, directly influencing guidelines for non-invasive disease characterization. Beyond this key contribution, Dr. Nassif’s research portfolio consistently advances the integration of PET/CT biomarkers into routine oncologic practice, aiming to improve diagnostic accuracy and guide therapeutic decisions. His work stands as a cornerstone for clinicians and researchers seeking to leverage PSMA-targeted imaging for better patient outcomes, cementing his reputation as a vital contributor to the field of precision oncology.
Research Focus
Key Achievements
Top Papers
- 1